Chronic pain after major breast surgery: A retrospective cohort study.

IF 6.8 2区 医学 Q1 ANESTHESIOLOGY
Victor Van Lishout, Steffen Rex, Steffen Fieuws, Sileny Han, An Teunkens
{"title":"Chronic pain after major breast surgery: A retrospective cohort study.","authors":"Victor Van Lishout, Steffen Rex, Steffen Fieuws, Sileny Han, An Teunkens","doi":"10.1097/EJA.0000000000002285","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Breast surgery is a cornerstone in the treatment of breast cancer but can cause persistent or worsening pain lasting beyond 3 months. Perioperative risk factors for chronic pain remain an area of ongoing research.</p><p><strong>Objective: </strong>To assess the incidence of chronic pain following breast surgery and identify its associated factors.</p><p><strong>Design: </strong>A retrospective cohort study.</p><p><strong>Setting: </strong>A single high-volume tertiary medical centre.</p><p><strong>Patients: </strong>Women undergoing first-time unilateral breast surgery as part of breast cancer treatment, without pre-existing chronic pain, between January 2020 and September 2022.</p><p><strong>Main outcome measures: </strong>The incidence of chronic postoperative pain at 3 and 6 months, pain scores, perioperative and in-hospital analgesic use, and predictive factors related to anaesthetic and treatment modalities.</p><p><strong>Methods: </strong>Univariable and multivariable analysis of peri-operative data associated with chronic postoperative pain at 3 and 6 months. A multivariable model was constructed by stepwise selection of data.</p><p><strong>Results: </strong>Chronic pain was reported in 32% (95% confidence interval (CI), 28.8 to 35.4%) of patients at 3 months and in 39% (95% CI, 35.9 to 42.2%) at 6 months postoperatively. During postanaesthetic care, 31% of patients recorded a pain score above four on the numeric rating scale (NRS), while 3% reported a score above seven. On subsequent days, the mean pain score fell below one. The use of sufentanil and propofol during general anaesthesia was strongly associated with a lower incidence of pain at 3 months, odds ratio (OR) 0.548 (95% CI 0.381 to 0.788) P = 0.0012, as well as sentinel node biopsy, OR 0.520 (95% CI 0.274 to 0.988) P = 0.0459. Adjuvant radiotherapy, OR 3.294 (95% CI 1.610 to 6.741) P = 0.0011, and the presence of chronic pain at 3 months, OR 10.706 (95% CI 7.399 to 15.489) P < 0.0001, were the strongest predictors of persistent pain at 6 months. Mastectomy, OR 0.610 (95% CI 0.456 to 0.817) P = 0.0009, and age, OR 0.983 (95% CI 0.972 to 0.995) P = 0.0051, were significantly associated after model construction.</p><p><strong>Conclusions: </strong>Multiple factors are associated with chronic pain following breast surgery. While perioperative factors play a role, long-term treatment modalities also significantly influence its occurrence.</p>","PeriodicalId":11920,"journal":{"name":"European Journal of Anaesthesiology","volume":" ","pages":""},"PeriodicalIF":6.8000,"publicationDate":"2025-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Anaesthesiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/EJA.0000000000002285","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ANESTHESIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Breast surgery is a cornerstone in the treatment of breast cancer but can cause persistent or worsening pain lasting beyond 3 months. Perioperative risk factors for chronic pain remain an area of ongoing research.

Objective: To assess the incidence of chronic pain following breast surgery and identify its associated factors.

Design: A retrospective cohort study.

Setting: A single high-volume tertiary medical centre.

Patients: Women undergoing first-time unilateral breast surgery as part of breast cancer treatment, without pre-existing chronic pain, between January 2020 and September 2022.

Main outcome measures: The incidence of chronic postoperative pain at 3 and 6 months, pain scores, perioperative and in-hospital analgesic use, and predictive factors related to anaesthetic and treatment modalities.

Methods: Univariable and multivariable analysis of peri-operative data associated with chronic postoperative pain at 3 and 6 months. A multivariable model was constructed by stepwise selection of data.

Results: Chronic pain was reported in 32% (95% confidence interval (CI), 28.8 to 35.4%) of patients at 3 months and in 39% (95% CI, 35.9 to 42.2%) at 6 months postoperatively. During postanaesthetic care, 31% of patients recorded a pain score above four on the numeric rating scale (NRS), while 3% reported a score above seven. On subsequent days, the mean pain score fell below one. The use of sufentanil and propofol during general anaesthesia was strongly associated with a lower incidence of pain at 3 months, odds ratio (OR) 0.548 (95% CI 0.381 to 0.788) P = 0.0012, as well as sentinel node biopsy, OR 0.520 (95% CI 0.274 to 0.988) P = 0.0459. Adjuvant radiotherapy, OR 3.294 (95% CI 1.610 to 6.741) P = 0.0011, and the presence of chronic pain at 3 months, OR 10.706 (95% CI 7.399 to 15.489) P < 0.0001, were the strongest predictors of persistent pain at 6 months. Mastectomy, OR 0.610 (95% CI 0.456 to 0.817) P = 0.0009, and age, OR 0.983 (95% CI 0.972 to 0.995) P = 0.0051, were significantly associated after model construction.

Conclusions: Multiple factors are associated with chronic pain following breast surgery. While perioperative factors play a role, long-term treatment modalities also significantly influence its occurrence.

乳房大手术后慢性疼痛:一项回顾性队列研究。
背景:乳房手术是乳腺癌治疗的基石,但可能导致持续或恶化的疼痛,持续时间超过3个月。慢性疼痛的围手术期危险因素仍是一个正在进行的研究领域。目的:探讨乳房手术后慢性疼痛的发生率及相关因素。设计:回顾性队列研究。环境:一个单一的大容量三级医疗中心。患者:在2020年1月至2022年9月期间,首次接受单侧乳房手术作为乳腺癌治疗的一部分,无既往慢性疼痛的女性。主要观察指标:术后3个月和6个月慢性疼痛发生率、疼痛评分、围手术期和院内镇痛药物的使用以及与麻醉和治疗方式相关的预测因素。方法:单变量和多变量分析与术后3和6个月慢性疼痛相关的围手术期数据。通过逐步选择数据,建立了多变量模型。结果:术后3个月慢性疼痛发生率为32%(95%可信区间(CI), 28.8 ~ 35.4%),术后6个月慢性疼痛发生率为39% (95% CI, 35.9 ~ 42.2%)。在术后护理期间,31%的患者在数字评定量表(NRS)上记录的疼痛评分在4分以上,而3%的患者报告的评分在7分以上。随后几天,平均疼痛评分降至1分以下。在全身麻醉期间使用舒芬太尼和异丙酚与3个月时较低的疼痛发生率密切相关,优势比(OR) 0.548 (95% CI 0.381至0.788)P = 0.0012,以及前哨淋巴结活检,OR 0.520 (95% CI 0.274至0.988)P = 0.0459。辅助放疗,OR为3.294 (95% CI 1.610 ~ 6.741) P = 0.0011, 3个月时存在慢性疼痛,OR为10.706 (95% CI 7.399 ~ 15.489) P结论:多种因素与乳房手术后慢性疼痛相关。虽然围手术期因素起作用,但长期治疗方式也显著影响其发生。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
6.90
自引率
11.10%
发文量
351
审稿时长
6-12 weeks
期刊介绍: The European Journal of Anaesthesiology (EJA) publishes original work of high scientific quality in the field of anaesthesiology, pain, emergency medicine and intensive care. Preference is given to experimental work or clinical observation in man, and to laboratory work of clinical relevance. The journal also publishes commissioned reviews by an authority, editorials, invited commentaries, special articles, pro and con debates, and short reports (correspondences, case reports, short reports of clinical studies).
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信